FACT: Institutions have been buying.(over 40% now) FACT: The JPAD peer reviewed article had 58 knowledgeable scientists sign it. FACT: The OLE data was very positive. More to come. FACT: EMA accepted the blarcamesine application (over 90% are approved) FACT: In a few months Anavex 3-71 phase 2 Schizophrenia data will come. FACT: EMA results by end of 2025 FACT: Submissions in UK, Canada and Australia expected by end 2025. FACT: The general market is rocky. FACT: Nothing Anavex can do about the general market. FACT: Nothing Anavex can do about Institutions holding down stock to buy. FACT: Many good biotechs are down. But a lot of good news has come and a lot is coming. I don't know a better stock to buy and hold!